Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1
Open Access
- 10 April 2011
- journal article
- research article
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 18 (5) , 604-613
- https://doi.org/10.1038/nsmb.2021
Abstract
Endoplasmic reticulum aminopeptidase 1 (ERAP1) has a crucial role in antigen presentation because it trims peptide ligands to 8–10 residues so that they fit into the peptide-binding groove of MHC class I molecules. The structure of the ERAP1 in complex with bestatin, an aminopeptidase inhibitor, reveals how the enzyme´s catalytic center how the enzyme can preferentially process peptides 10–15 residues long while sparing shorter ones and provides the first evidence that substrate binding induces conformational changes. ERAP1 trims antigen precursors to fit into MHC class I proteins. To fulfill this function, ERAP1 has unique substrate preferences, trimming long peptides but sparing shorter ones. To identify the structural basis for ERAP1's unusual properties, we determined the X-ray crystal structure of human ERAP1 bound to bestatin. The structure reveals an open conformation with a large interior compartment. An extended groove originating from the enzyme's catalytic center can accommodate long peptides and has features that explain ERAP1's broad specificity for antigenic peptide precursors. Structural and biochemical analyses suggest a mechanism for ERAP1's length-dependent trimming activity, whereby binding of long rather than short substrates induces a conformational change with reorientation of a key catalytic residue toward the active site. ERAP1's unique structural elements suggest how a generic aminopeptidase structure has been adapted for the specialized function of trimming antigenic precursors.This publication has 59 references indexed in Scilit:
- Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimmingProceedings of the National Academy of Sciences, 2011
- Investigating the genetic association between ERAP1 and ankylosing spondylitisHuman Molecular Genetics, 2009
- Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading EnzymeBiochemistry, 2008
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsNature Genetics, 2007
- ERAAP Synergizes with MHC Class I Molecules to Make the Final Cut in the Antigenic Peptide Precursors in the Endoplasmic ReticulumImmunity, 2006
- Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanismNature, 2006
- Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active siteProceedings of the National Academy of Sciences, 2006
- Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptidesin vivoand plays an important role in immunodominanceProceedings of the National Academy of Sciences, 2006
- [20] Processing of X-ray diffraction data collected in oscillation modePublished by Elsevier ,1997